Lodo Therapeutics Acquires Conifer Point Pharmaceuticals

Expands AI/ML Capabilities and Gains Exclusive Rights to Leading Suite of Cheminformatics Technologies Conifer Point's Technologies Enable Expansion of Lodo's P4 Platform™ to Include Therapeutic Target-Based De Novo Drug Discovery Represents Major Ad... Biopharmaceuticals, Mergers & Acquisitions, Personnel Lodo Therapeutics, Conifer Point Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news